Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma

Acta Oncologica

Volumn 52, Issue 1, 2013, Pages 147-152

  Combs, Stephanie E ^a   Edler, Lutz ^b   Rausch, Renate ^b   Welzel, Thomas ^a   Wick, Wolfgang ^a   Debus, Jürgen ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE TOXICITY; ADOLESCENT; ADULT; AGED; ALOPECIA; ANAPLASTIC GLIOMA; ARTICLE; ASTROCYTOMA; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; ERYTHEMA; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; GLIOBLASTOMA; GLIOMA; HEADACHE; HISTOLOGY; HUMAN; IRRADIATION; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NAUSEA; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECURRENT CANCER; REIRRADIATION; SCHOOL CHILD; TUMOR VOLUME; AGE; CANCER PATIENT; PROGNOSTIC ASSESSMENT; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RE-IRRADIATION; TIME; TUMOR RECURRENCE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; CHILD; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETREATMENT; TIME-TO-TREATMENT; YOUNG ADULT;

EID: 84871413280     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.692882     Document Type: Article

References (20)

1. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D. Effi cacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol 2005;23:8863 - 9. (Pubitemid 46211533)
2. Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 1996;36:433 - 41. (Pubitemid 26359470)
3. Arcicasa M, Roncadin M, Bidoli E, Dedkov A, Gigante M, Trovo MG. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 1999;43:789 - 93. (Pubitemid 29152651)
4. Combs SE, Gutwein S, Thilmann C, Debus J, Schulz-Ertner D. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlenther Onkol 2005;181:768 - 73. (Pubitemid 41813702)
5. Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: A benefi cial treatment option after high-dose radiotherapy? Strahlenther Onkol 2009;185:235 - 40.
6. Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, et al. Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol 2009;185: 113 - 9.
7. Pollack IF. Neuro-oncology: Therapeutic benefi ts of reirradiation for recurrent brain tumors. Nat Rev Neurol 2010;6:533 - 5.
8. Rasmussen KH, Hardcastle N, Howard SP, Tome WA. Reirradiation of glioblastoma through the use of a reduced dose rate on a tomotherapy unit. Technol Cancer Res Treat 2010;9:399 - 406.
9. Park JK, Hodges T, Arko L, Shen M, Dello ID, McNabb A, et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 2010; 28:3838 - 43.
10. Karger CP, Hipp P, Henze M, Echner G, Hoss A, Schad L, et al. Stereotactic imaging for radiotherapy: Accuracy of CT, MRI, PET and SPECT. Phys Med Biol 2003;48:211 - 21. (Pubitemid 36204157)
11. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 1999;17:2572 - 8. (Pubitemid 29368260)
12. Wick A, Pascher C, Wick W, Jauch T, Weller M, Bogdahn U, et al. Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 2009;256:734 - 41.
13. Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, et al. Effi cacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. J Clin Oncol 2007;25:3357 - 61. (Pubitemid 47325623)
14. Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998;42:709 - 20.
15. Niyazi M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, Geisler J, et al. Irradiation and bevacizumab in high-grade glioma retreatment settings. Int J Radiat Oncol Biol Phys 2012;82:67 - 76.
16. Dirks P, Bernstein M, Muller PJ, Tucker WS. The value of reoperation for recurrent glioblastoma. Can J Surg 1993;36:271 - 5. (Pubitemid 23248140)
17. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM). Cancer 2005;104:2168 - 73. (Pubitemid 41579963)
18. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008;70:1350 - 60. (Pubitemid 351417752)
19. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459 - 66.
20. Combs SE, Wagner J, Bischof M, Welzel T, Edler L, Rausch R, et al. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys 2008;71:999 - 1005.